Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.1 USD | +1.89% | +4.97% | +1.12% |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
May. 10 | Novartis Gets FDA Breakthrough Therapy Designation for Scemblix | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVARTIS AG | Other Pharmaceuticals | +1.89% | +4.97% | +1.12% | -1.28% | +24.69% | 208B |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVN Stock
- NVS Stock
- Charts Novartis AG
- Comparison Chart